Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1143420230160351233
Public Health Weekly Report
2023 Volume.16 No. 35 p.1233 ~ p.1254
A Case Study on the Decision-making of Non-pharmaceutical Interventions
Jung Ung-Ki

Kim Sang-June
Jang Young-Ook
Aum Ji-Eun
Kim Da-Sol
Jung Tong-Ryoung
Abstract
To cope with the coronavirus disease 2 019 (COVID-19) pandemic, non-pharmaceutical interventions (NPIs) policies were introduced around the world, with significant socioeconomic costs being simultaneously incurred. For the NPIs to be effectively implemented, public acceptance of them must be thus considered. In the process of incorporating scientific evidence into policy decisions, different interests, values, or beliefs among societal groups needs to be comprehensively discussed and deliberated. In this study, we focus on two dimensions of the contradictory dynamics that a relation between science and policy would give rise to: the politics of health policy and the politics of evidence. Based on the literature review and consultations from expert seminars we organized, comparative case analysis is employed to explore how decision-making on NPIs was made in the United States (US), the United Kingdom (UK), Denmark, and Taiwan. To be specific, science advice mechanisms are examined in the cases of the US and UK, while the use of behavioral science expertise in Denmark and how civic technology governance works in Taiwan are briefly discussed as policy innovations during the pandemic. We conclude with recommendations for Korean¡¯s policymakers. They include risk communication strategies firmly based on behavioral and social science expertise and the activation of better science advice mechanisms.
KEYWORD
Non-pharmaceutical intervention, COVID-19, Public Health, Infectious disease
FullTexts / Linksout information
Listed journal information